Federal Register / Vol. 62, No. 167 / Thursday, August 28, 1997 / Notices 45633

Date of Meeting: September 23–25, 1997

from 0800 to 1700.

Place: National Highway Institute

Conference Room 302, 901 North Stuart

Street, Arlington, VA.

Matters to be Considered: Research and

Development proposals and continuing

projects requesting Strategic Environmental

Research and Development Program funds in

excess of $1M will be reviewed.

This meeting is open to the public. Any

interested person may attend, appear before,

or file statements with the Scientific

Advisory Board at the time and in the

manner permitted by the Board.

For Further Information Contact: Ms. Amy

Levine, SERDP Program Office, 901 North

Stuart Street, Suite 303, Arlington, VA or by

telephone at (703) 696–2124.

Dated: August 22, 1997.

L.M. Bynum,

Alternate OSD Federal Register Liaison

Officer, Department of Defense.

[FR Doc. 97–22862 Filed 8–27–97; 8:45 am]

BILLING CODE 5000–04–M

DEPARTMENT OF DEFENSE

Department of the Air Force

Record of Decision (ROD) for the

Disposal and Reuse Final

Environmental Impact Statement for

McClellan Air Force Base (AFB),

California (CA)

On August 19, 1997, the Air Force

issued a ROD for the disposal of

McClellan Air Force Base (AFB), CA.

The decisions included in this ROD

have been made in consideration of the

Final Programmatic Environmental

Impact Statement for the Disposal and

Environmental Impact Report for Reuse

(FPEIS/EIR) of McClellan AFB, CA,

which was filed with the Environmental

Protection Agency on July 3, 1997, and

other relevant considerations.

McClellan AFB will officially close on

July 13, 2001, pursuant to the Defense

Base Closure and Realignment Act of

1990, (Pub. L. 101–510) and the

recommendations of the Defense

Secretary’s Commission on Base

Realignment and Closure. This ROD

documents the McClellan AFB disposal

decisions.

The Air Force has decided to dispose

of the approximately 3,452 acres fee and

93 acres of easements of McClellan AFB

and associated off base sites in the

following manner: Parcel A

(approximately 6 acres), Parcel B

(approximately 8 acres), Parcel C

(approximately 13 acres), Parcel D1

(approximately 1 acre), Parcel E

(approximately 14 acres), Parcel F

(approximately 3 acres) will be retained

by Department of Defense; Parcel G

(approximately 5 acres) and Camp

Kohler Annex (approximately 35 acres)

will be transferred to the Department of

Transportation Federal Aviation

Administration for aviation use; Parcel

H (approximately 39 acres) will be

transferred to the County of Sacramento

Board of Supervisors which is the

official Local Redevelopment Authority

(LRA) for federal leaseback for the

Department of Transportation United

States Coast Guard for air rescue

operations; Parcel I (approximately 1

acre) and McClellan Hospital Complex

(approximately 26 acres) will be

transferred to the Department of

Veterans Affairs for a hospital and

dental clinic; Parcel J (approximately

2,415 acres) will be transferred to the

LRA for the establishment of an aviation

technology center; Parcel K

(approximately 1 acre) will be offered as

a negotiated sale to Sacramento Area

Federal Employees (SAFE) Credit

Union; Parcel DC–1 (approximately 115

acres) will be transferred to the

Department of Interior United States

Fish and Wildlife Service to protect and

manage natural habitats and wetlands;

and Parcel DC–2 (approximately 5 acres)

will be transferred to the Department of

Commerce National Oceanic and

Atmospheric Administration National

Weather Service for weather

surveillance. The decision on the

remaining land and facilities has been

deferred until a later date.

The uses proposed for the property by

the prospective recipients of the

property under the ROD are included in

the proposed action in the FPEIS/EIR

and are consistent with the

community’s revised redevelopment

plan for the base. The LRA prepared the

plan with the assistance of the broader

community.

By this decision, the Air Force adopts

certain mitigation measures, as

described in this ROD, to protect public

health and the environment. In response

to the existing or forecasted

environmental impacts to or in the area

of McClellan AFB, subsequent property

owners should consider implementation

of the more specific mitigation measures

associated with reuses they may

undertake, as set forth in Chapter 4 of

the PFEIS.

Any questions regarding this matter

should be directed to Mr. Charles R.

Hatch, Program Manager, Division C.

Correspondence should be sent to

AFBCA/DC, 1700 North Moore Street,

Suite 2300, Arlington, VA 22209–2809.

Barbara A. Carmichael,

Alternate Air Force Federal Register Liaison

Officer.

[FR Doc. 97–22965 Filed 8–27–97; 8:45 am]

BILLING CODE 3910–01–P

DEPARTMENT OF DEFENSE

Department of the Army

Availability of Non-Exclusive,

Exclusive, or Partially Exclusive

Licensing of U.S. Patent Application

Concerning ‘‘Bacterial Superantigen

Vaccines’’

AGENCY: U.S. Army Medical Research

and Materiel Command, DoD.

ACTION: Notice of availability.

SUMMARY: In accordance with 38 CFR

404.6, announcement is made of the

availability of U.S. Patent Application

SN 08/882,431 entitled ‘‘Bacterial

Superantigen Vaccines.’’ This patent has

been assigned to the United States

Government as represented by the

Secretary of the Army.

ADDRESSES: Commander, U.S. Army

Medical Research and Materiel

Command, Command Judge Advocate,

MCMR–JA, 504 Scott Street, Fort

Detrick, MD 21702–5012.

FOR FURTHER INFORMATION CONTACT:

Mr. John F. Moran, Patent Attorney,

301–619–7807, Fax 301–619–5034.

SUPPLEMENTARY INFORMATION:

‘‘Recombinant vaccines for control of

bacterial superantigen-associated

diseases have been developed. These

include vaccines of staphylococcal

enterotoxin A, staphylococcal

enterotoxin B, staphylococcal

enterotoxin C1, toxic-shock syndrome

toxin-1, and streptococcal pyrogenic

exotoxin-A. Engineered changes in the

proteins have attenuated receptor

binding and biological activity to an

essentially nonspecific level. The

vaccines retain a high degree of

antigenicity and have been successfully

tested in murine and nonhuman primate

animal models for protective immunity

and safety. These vaccines offer the

safety and advantages of defined

recombinant proteins and may be useful

for controlling toxic-shock syndromes

and certain autoimmune diseases

associated with these bacterial

superantigens.’’

Gregory D. Showalter,

Army Federal Register Liaison Officer.

[FR Doc. 97–22872 Filed 8–27–97; 8:45 am]

BILLING CODE 3710–08–M

DEPARTMENT OF DEFENSE

Office of the Secretary

Defense Intelligence Agency, Science

and Technology Advisory Board

Closed Meeting

AGENCY: Defense Intelligence Agency,

Department of Defense.